United Therapeutics Corporation Temporary Equity, Redemption Value (Deprecated 2014-01-31)
United Therapeutics Corporation (UTHR) had Temporary Equity, Redemption Value (Deprecated 2014-01-31) of $10.88 million as of 2013-03-31, per its 10-Q filed 2013-04-25.
Discontinued › Notes
us-gaap:TemporaryEquityRedemptionValue · last filed 2013-04-25
- 2013-03-31: Temporary Equity, Redemption Value (Deprecated 2014-01-31) $10.88M.
- 2012-12-31: Temporary Equity, Redemption Value (Deprecated 2014-01-31) $10.88M.
- 2012-09-30: Temporary Equity, Redemption Value (Deprecated 2014-01-31) $10.88M.
- 2012-06-30: Temporary Equity, Redemption Value (Deprecated 2014-01-31) $10.88M.
| Period end | Temporary Equity, Redemption Value (Deprecated 2014-01-31) |
|---|---|
| 2013-03-31 | $10.88M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $10.88M 10-Q · filed 2013-04-25 |
| 2012-09-30 | $10.88M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $10.88M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $10.88M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $10.88M 10-K · filed 2013-02-26 |
| 2011-09-30 | $10.88M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $10.88M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $10.88M 10-Q · filed 2011-04-28 |
| 2010-12-31 | $10.88M 10-K · filed 2012-02-28 |
| 2010-09-30 | $10.88M 10-Q · filed 2010-10-28 |
| 2010-06-30 | $10.88M 10-Q · filed 2010-07-28 |
| 2009-12-31 | $10.88M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |